IDEAYA Biosciences Inc (NASDAQ:IDYA)
| 20.35 Delayed Data As of 3:59pm ET |  +0.83 / +4.25%Today’s Change | 2.95 Today|||52-Week Range 21.38 | +45.36% Year-to-Date |
Latest IDYA News | Press Releases
No recent news for IDEAYA Biosciences Inc.
Today’s Trading
| Previous close | 19.52 |
| Today’s open | 19.42 |
| Day’s range | 19.40 - 20.41 |
| Volume | 7,617 |
| Average volume (3 months) | 212,444 |
| Market cap | $547.1M |
Data as of 3:59pm ET, 03/02/2021
Growth & Valuation
| Earnings growth (last year) | -97.82% |
| Earnings growth (this year) | +57.94% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRNSMarinus Pharmaceutic... | 0.00 | 0.00% |
| FLXNFlexion Therapeutics... | -0.32 | -2.81% |
| TXMDTherapeuticsMD Inc | +0.00 | +0.35% |
| GMDAGamida Cell Ltd | -0.43 | -4.37% |
Data as of 4:00pm ET, 03/02/2021
Financials
| Next reporting date | March 30, 2021 |
| EPS forecast (this quarter) | -$0.34 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$42.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
